Advanced Filters
noise

Beverwijk, Netherlands Clinical Trials

A listing of Beverwijk, Netherlands clinical trials actively recruiting patients volunteers.

Found 39 clinical trials

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with gastrointestinal (GI)/genitourinary (GU) cancer associated VTE (Magnolia)

18 - 100 years of age Both Phase 3
M Mehmet Kurkcu

Musical Intervention During IV-line Placement in Neonates

The goal of this clinical trial is to test the effect of music in reducing the pain felt by newborn children during an intravenous line procedure. An intravenous line is a small tube brought into a vein by using a needle. The main questions it aims to answer are: Does …

- 100 years of age Both Phase N/A
M Marc Govaert, Dr.

Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial

Rationale Perianal fistula is a burdening disease with an annual prevalence of 2/100.000 in the Dutch population. More than 90% of crypto-glandular fistulas originate from anorectal abscess. Despite adequate drainage of anorectal abscess up to 83% recurs or results in an anal fistula, the majority developing within 12 months. Up …

18 - 100 years of age Both Phase N/A

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children

This phase IIb trial aims to evaluate the efficacy and safety of EHSG-KF (synonym denovoSkin) in comparison to meshed STSG in children with partial deep dermal and full thickness burns.

- 12 years of age Both Phase 2/3
M Marieke van de Belt

Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer

In this exploratory study, patients with stage 1-3 adenocarcinoma of the colon with no signs of distant metastases will be treated with short-term immunotherapy + novel IO combinations (i.e. anti-IL 8, COX2-inhibitors). This treatment will be given during the window period until surgical resection of the tumor. The duration of …

18 - 100 years of age Both Phase 2

Flow Dysfunction of Hemodialysis Vascular Access

The FLOW trial evaluates the follow-up of the vascular access for hemodialysis. In current clinical care, vascular access flow volume is periodically assessed to detect and treat asymptomatic stenosis. The FLOW trial will determine whether it is safe to abandon this practice of active surveillance. Vascular access stenosis will then …

18 - 100 years of age Both Phase N/A

Transforaminal Epidural Injection in Acute Sciatica

Patients suffering from sciatica are treated conservatively for the first 8 weeks due to the favourable prognosis. This period is preferably extended up to 14-16 weeks after which patients may opt for surgery. However, patients may experience severe discomfort due to pain in the leg which can lead to decreased …

18 - 100 years of age Both Phase N/A

Optimizing Access Surgery In Senior Hemodialysis Patients

The number of elderly hemodialysis patients is growing. Vascular access complications are a major determinant of the quality of life and health care costs for these vulnerable patients. The three different types of vascular access, i.e. autologous arteriovenous fistulas, arteriovenous grafts, and central venous catheters, have never been compared in …

65 - 100 years of age Both Phase N/A

Enhancing Work Participation of Unemployed and Work-Disabled Cancer Survivors

The primary objective of this study is to evaluate the effectiveness of the PLACES intervention on paid employment re-entry in unemployed and work-disabled cancer survivors, compared to CAU. Secondary Objectives are: To evaluate the cost-effectiveness of the PLACES intervention aimed at unemployed or work-disabled cancer survivors. To evaluate the effectiveness …

18 - 65 years of age Both Phase 2/3
K K.S. Versteeg, MD, PhD

Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases

The purpose of this study is to compare overall survival rates of colorectal cancer patients with multi-organ metastases with an indication for first line systemic treatment randomized for treatment with combination chemotherapy or treatment with combination chemotherapy and additional maximal tumor debulking including surgical tumor resection, RFA, (DEBIRI-)TACE and SBRT, …

18 - 100 years of age Both Phase N/A

Rewrite in simple language using AI